Article
The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease
8 Sept 2022
Abstract excerpt
Graft-versus-host disease (GVHD), manifesting as either acute (aGVHD) or chronic (cGVHD), presents significant life-threatening complications following allogeneic hematopoietic cell transplantation. Here, we investigated Friend virus leukemia integration 1 (Fli-1) in GVHD pathogenesis and validated Fli-1 as a therapeutic target. Using genetic approaches, we found that Fli-1 dynamically regulated different T cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
